MarketCap
Ironwood Pharmaceuticals IRWD
$ 3.75
7.14%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2010 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
162 M |
Market Cap[1] |
$ 607 M |
EBITDA (LTM) |
$ 99.6 M |
P/E (LTM) |
-426.0 |
P/S (LTM) |
14.451087 |
EPS (LTM) |
-0.01 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.76 | 3.18 % | $ 12.3 B | NYSE |  India |
 |
Replimune Group
REPL
|
$ 20.68 | 0.12 % | $ 1.92 B | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Avidity Biosciences
RNA
|
$ 8.67 | -0.57 % | $ 1.19 B | Nasdaq Global Select Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 67.56 | 1.75 % | $ 29 B | Nasdaq Global Select Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 9.95 | -1.58 % | $ 1.39 B | Nasdaq Global Select Market |  France |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 105.17 | 21.67 % | $ 6.83 B | Nasdaq Global Market,SPB | USA |
 |
Sana Biotechnology
SANA
|
$ 2.56 | 4.92 % | $ 648 M | Nasdaq Global Select Market | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.98 | 3.7 % | $ 304 M | Nasdaq Capital Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 66.7 | 4.53 % | $ 186 M | Nasdaq Global Select Market |  Israel |
 |
SELLAS Life Sciences Group
SLS
|
$ 9.15 | 3.1 % | $ 998 M | Nasdaq Capital Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Syndax Pharmaceuticals
SNDX
|
$ 10.48 | -26.94 % | $ 908 M | Nasdaq Global Select Market | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
Sanofi
SNY
|
$ 47.45 | 4.67 % | $ 57.9 B | Nasdaq Global Select Market | France |
 |
CNS Pharmaceuticals
CNSP
|
$ 4.21 | -7.47 % | $ 1.87 M | Nasdaq Capital Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.07 | 2.88 % | $ 59.9 M | Nasdaq Global Select Market | USA |
 |
DiaMedica Therapeutics
DMAC
|
$ 10.79 | 7.85 % | $ 507 M | Nasdaq Capital Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 18.97 | 2.32 % | $ 1.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 21.07 | 1.52 % | $ 33.3 B | NYSE |  Japan |
 |
Tarsus Pharmaceuticals
TARS
|
$ 69.01 | -5.0 % | $ 2.88 B | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.8 | 0.19 % | $ 11.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 41.97 | 0.14 % | $ 48.1 B | NYSE | Israel |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
Precision BioSciences
DTIL
|
$ 8.01 | 14.92 % | $ 103 M | Nasdaq Global Select Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | USA |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 5.12 | -1.45 % | $ 43.6 M | Nasdaq Global Select Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 4.34 | 5.99 % | $ 1.39 B | Nasdaq Global Select Market | USA |
 |
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | USA |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.56 | -2.77 % | $ 6.2 M | Nasdaq Capital Market | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 1.2 | 9.63 % | $ 24.7 M | NYSE American | USA |
 |
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Vericel Corporation
VCEL
|
$ 45.83 | 11.54 % | $ 2.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | USA |
 |
Veracyte
VCYT
|
$ 52.31 | 4.02 % | $ 4.11 B | Nasdaq Global Market,SPB | USA |
 |
Exelixis
EXEL
|
$ 72.73 | 0.58 % | $ 19.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Vir Biotechnology
VIR
|
$ 11.67 | 4.01 % | $ 1.62 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.